Medical Grade
The EU's Good Manufacturing Practices set the foundation for our best-practice production plan, in full compliance with CUMCS regulations across every stage of the cultivation and processing cycle.
A 50,000 square-meter site with 30,000 square meters of production space, operating in a hybrid greenhouse environment built for pharmaceutical and medical markets.
Ocsas Pharma operates a medical cannabis growing facility in strict conformity with GACP and CUMCS-GAP principles, designed for the cultivation, extraction, and processing of medical cannabis for the pharmaceutical and medical markets.
Hybrid greenhouse environment
The greenhouse harnesses the majority of the sun's energy and elevates the quality of medical cannabis flower throughout each plant's life cycle. The innovative greenhouse design increases terpene and resin development by working with, rather than against, natural light.
Patients receive product that is finely cured and polished, the result of an exclusive growing method paired with cutting-edge processing.
Single site, purpose-built for medical cannabis cultivation, extraction, and processing in a controlled, pharmaceutical-grade environment.
Active production area within the hybrid greenhouse, optimised for terpene density, resin development, and flower integrity.
Sunlight powers our greenhouses, providing the best growing conditions and dramatically reducing the energy footprint of pharmaceutical-grade medical cannabis production.
Three principles shape every facility decision: pharmaceutical grade by default, energy efficiency by design, and accessibility built into our pricing.
The EU's Good Manufacturing Practices set the foundation for our best-practice production plan, in full compliance with CUMCS regulations across every stage of the cultivation and processing cycle.
Aiming to produce certified organic medical cannabis at the highest level, Ocsas Pharma uses sunlight as the primary energy source for our greenhouses, delivering optimal growing conditions with a fraction of the energy footprint.
Compassionate pricing reflects our values around accessibility for all, while simultaneously increasing our competitiveness as a supplier to global pharmaceutical and therapeutic markets.
For Ocsas Pharma, the quality and consistency of the medical cannabis product matter more than production yield. Expertise is required to adapt cultivation techniques to compensate for local environmental factors and seasonal change.
That expertise translates into a process where every step is intentional: every batch is documented, every plant is monitored, and every harvest is judged against the same pharmaceutical standard.
Cultivation facilities are laid out, and QA/QC systems are designed, in accordance with Good Agricultural Practice principles. Every step of cultivation is logged and verified.
Stringent harvesting, drying, mixing, and extraction methods ensure that every patient receives product of the highest, most consistent quality with every order.
In-house scientists conduct comprehensive testing on every medical cannabis product. Certified third-party laboratories verify against impurities including microbiological pollutants, heavy metals, pesticides, and aflatoxins.
For facility tours, certification documentation, or procurement enquiries, our team is ready to discuss the next step.